RenovoRx Q3 Adj. EPS $(0.08) Misses $(0.06) Estimate, Sales $1.066M Beat $1.065M Estimate
Benzinga Newsdesk 3 hours ago
NewsEarningsEarnings BeatsEarnings Misses
RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is unchanged from the same period last year. The company reported
RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.066 million which beat the analyst consensus estimate of $1.065 million by 0.14 percent. This is a 300.75 percent increase over sales of $266.000 thousand the same period last year.